W hile neoangiogenesis in diabetes is of greatest clinical significance in the retina, the pathological formation of new blood vessels also develops in other vascular beds in diabetes, including the mesentery of the streptozotocin-induced diabetic rat. However, the contribution of bone marrow-derived cells to this process of vasculogenesis is unknown.
Introduction
Structural and functional abnormalities that develop in the microvasculature in diabetes include increased permeability, extracellular matrix deposition and neovascularisation. These changes may have profound clinical significance as pathogenetic mechanisms that underlie the development of nephropathy and vision-threatening retinal disease in diabetes. Rather than being restricted to the retina and kidney, the microvascular changes of diabetes may be more widespread, though their clinical significance is clearly sitedependent. 1 For instance, increased vascular permeability has also been noted in the skin of both humans 2 and animals 3 with diabetes. Similarly, while its clinical correlate is uncertain, the mesenteric vasculature in animals also displays characteristic microvascular pathological changes following the induction of experimental diabetes. These changes include hypertrophy, 4 hyperpermeability 5 and the formation of new blood vessels (neoangiogenesis). 5, 6 Until recently, the formation of new blood vessels in the mature animal was thought to be mediated exclusively by endothelial cell sprouting from pre-existing capillaries. 7 However, it has now become apparent that bone marrowderived angioblasts also contribute to post-natal new vessel formation. 8, 9 These bone marrow-derived cells express the stem cell factor receptor, c-kit, 8 a transmembrane tyrosine kinase that is confined in the adult to bone marrow progenitors, mast cells, immature thymocytes and certain malignancies. 10 Migration of such cells is responsive to specific chemokines, particularly those of the CXC subset. 11 Indeed, recent studies have emphasised the importance of the CXC chemokine stromal derived factor-1 alpha (SDF-1 alpha), that through interaction with its receptor CXCR4 (also known as fusin, LESTR and HUMSTER) not only mediates the homing of progenitor cells back to bone marrow but also recruits their participation in neoangiogenesis at extramedullary sites. 12 Accordingly, in the present study we sought to examine the participation of cells that express c-kit in diabetic mesenteric angiogenesis and to determine the expression of SDF-1 during this process.
Methods

Animals
Forty male Sprague-Dawley rats aged eight weeks and weighing between 200 and 250 grams were randomised to receive streptozotocin (STZ) at a dose of 45 mg/kg (diabetic) or citrate buffer alone (control). Rats were given ad libitum access to water and standard chow containing 20% protein (Clark, King & Co, Melbourne, Australia). Only STZ-treated animals with plasma glucose levels > 15 mmol/L were considered diabetic and included in the study.
Diabetic animals were not treated with insulin and were sacrificed at three weeks following STZ injection. Immediately prior to sacrifice, rats were weighed and systolic blood pressure was determined by tail cuff plethysmography. 13 Animals were then anaesthetised with pentobarbital sodium (Nembutal, Bomac Laboratories, Asquith, Australia) and their vessels were perfused at arterial pressure with 10% neutral buffered formalin (n=20) or normal saline (n=20) via an intra-aortic cannula.
Tissues were prepared as previously described, 4 with vessel either embedded in paraffin (formalin fixed) for histological analysis or snap frozen in liquid nitrogen for gene expression analysis. All principles of laboratory animal care from the National Health and Medical Research Foundation of Australia were followed.
Capillary density
To assess capillary density, tissue sections were incubated with the endothelial cell marker Banderia simplicifolia isolectin (Australian Laboratory Services, Sydney, Australia), as previously described. 14 In brief, sections were immersed in isolectin 1:90, diluted in 0.1 M phosphate-buffered saline (PBS) at pH 7.4 for three hours at room temperature, washed thoroughly with PBS (3 x 5-minute changes), flooded with hydrogen peroxide diluted 1:4 with methanol for 10 minutes, rinsed with PBS, then incubated with the avidinbiotin-peroxidase complex (Vector Laboratories Inc, Burlingame, CA, US). Capillaries, identified by their luminal structure and isolectin labelling, were counted under light microscopy (X200) from five randomly chosen fields, as previously described. 15 Histochemistry and immunohistochemistry Following routine tissue preparation, 4 histochemical and immunohistochemical studies were performed on 3 µm tissue sections. Sections were also immunostained using an affinity-purified polyclonal rabbit antibody directed against the carboxy terminal domain of c-kit (Lab Vision, Fremont, CA), anti-von Willebrand Factor (vWF) antibody (DAKO A/S, Copenhagen, Denmark) and anti-CXCR4 (Santa Cruz Biotechnology, Santa Cruz, CA). Immunohistochemistry was performed using the indirect avidin-biotin complex (Vector), method, as previously described. 16 Histochemical staining comprised the use of haematoxylin and eosin.
Double staining
Double staining and confocal microscopy was performed as previously described. 17 In brief, 6 µm frozen sections were fixed with acetone for five minutes at 4°C and washed with PBS (pH 7.4). Sections were then incubated with 1:10 normal goat serum for 30 minutes at room temperature before being incubated with rabbit anti-kit antibody (Lab Vision) overnight at 4°C.
The following day sections were thoroughly washed with PBS and labelled with Alexa 568 goat anti-rabbit (Molecular probes, OR, 1:100) for one hour at room temperature. The sections were then rinsed with PBS and Double staining block (Dako, US) applied for 20 minutes at room temperature. Rabbit anti vWF (1:200) was applied to the sections overnight at 4°C before a thorough wash with PBS the following day. The sections were then labelled with FITC conjugated swine anti-rabbit (Dako, 1:100) for one hour at room temperature.
Finally, the sections were washed with PBS and coverslipped before viewing with a Leica Confocal microscope with a 63 times oil immersion lens. Sections were excited at 488 nm and filtered to 520 nm (FITC, green, pane 1) and also at 568 nm and filtered to 590 nm (Alexa, red, pane 2). Images were captured using a sequential imaging method. Negative controls included omitting the primary antibodies.
Quantitative real time RT-PCR
Quantitative real time RT-PCR was performed, as previously described. 18 In brief, frozen mesenteric vascular tissue, stored at -80°C, was homogenised (Polytron, Kinematica GmbH, Littau, Switzerland) and total RNA was isolated using TRIzol reagent (Life Technologies, Grand Island, NY). The purified RNA was dissolved in sterile water and quantified spectrophotometrically (OD260). RNA quality was verified on a 1% denaturing agarose gel. Four micrograms of total RNA was treated with RQ1 DNAse (1 U/µl) (Promega, Madison, WI) to remove genomic DNA.
The DNase-treated RNA was reverse transcribed with 1 µl (2 µg/µl) random hexamers (Roche Diagnostics, Mannheim, Germany) and incubated for five minutes at 70°C. After cooling on ice for five minutes, 5 µl of 5x AMV reaction buffer, 2.5 µl of 10 mM dNTP mix, 0.5 µl RNase inhibitor (40 U/µl) (Roche Diagnostics, Mannheim, Germany), 0.5 µl AMV reverse transcriptase (25U/µl) (Roche Diagnostics, Mannheim, Germany) and 4.5 µl of DEPC water was added. Tubes were incubated at 37°C for 60 minutes, after which cDNA samples were stored at -20°C for future use.
SDF-1 gene expression was quantified by real-time RT-PCR using the sequence specific forward primer: GCTCTG-CATCAGTGACGGTAAG; reverse primer: TGGCGACATG-GCTCTCAAA and probe: CTGAGCTACAGATGCCCCTGC-CGATT. A commercial, pre-developed 18S control kit labelled with the fluorescent reporter dye (VIC) on the 5' end, and the quencher (TAMRA) on the 3' end (PE Biosystems, Foster City, CA) was used as the housekeeping ORIGINAL ARTICLE 
Results
Animal data
All animals injected with STZ developed diabetes, as defined as plasma glucose > 15 mmol/L. Diabetes was associated with reduced weight gain despite increased food intake (table 1). Mesenteric vessel weight was significantly increased in diabetic rats, as was blood pressure (table 1) .
Capillary density
Lectin labelling of endothelial cells showed only few capillaries to be present in non-diabetic mesenteric tissue. In contrast, diabetes was associated with a dramatic increase in capillary density (figure 1). Representative photomicrographs are shown in figure 1 .
Immunohistochemistry
Immunostaining of formalin-fixed sections showed abundant c-kit-positive (c-kit + ) cells in the mesentery of diabetic but not control rats ( figure 2) . Under high power, these cells were of varying morphological appearance, with many rounded cells showing evidence of lumen formation at various stages of development as well as large, more amorphous cells with abundant cytoplasm (figure 2). 
C
Double staining
Immunofluorescence microscopy showed cells in immature vessels that expressed both c-kit and vWF ( figure 3A) . Also noted were other c-kit-positive cells that did not appear to be forming vessels. These cells did not co-express vWF (figure 3B ). On the other hand larger, more mature appearing vessels displayed only vWF and not c-kit immunolabelling ( figure 3B ). All c-kit-labelled cells also co-expressed the SDF-1 receptor, CXCR-4 ( figure 4 ). Negative controls did not exhibit fluorescent labelling.
Gene expression
Gene expression studies showed that, at three weeks, mesenteric SDF-1 mRNA was substantially increased in diabetic animals when compared with controls ( figure 5 ).
Discussion
While the contribution of cells of bone marrow origin to postnatal vasculogenesis has been well documented, 7 its participation in diabetic pathology has not been previously recognised. In the present study we demonstrate that c-kit+ cells, indicative of bone marrow origin, contribute to new vessel formation in the diabetic mesentery. In addition, a five-fold increase in the expression of the angiogenic chemokine SDF-1 was measured. These data support the notion that postnatal vasculogenesis occurs in diabetes, which has implications for understanding the pathogenetic mechanisms that underlie the neovascularisation that develops as a complication of this disorder. Endothelial cells, the foundation of the vasculature, can be derived from at least three potential sources: mature endothelial cells, bone marrow 19 and bone marrow-derived progenitor cells located in the vessel adventitia. 20 In the embryo and also in the bone marrow of mature animals, the haemangioblast, a pluripotential stem cell, may contribute both to the formation of blood elements and to blood vessels. 19 Such cells subsequently differentiate, giving rise to lineage-committed haematopoietic precursors (monocyte/ granulocyte, megakaryocyte or erythroid) or endothelial progenitor cells (EPCs). 21 Both the haematopoietic stem cell and endothelial progenitor cell fully express the stem cell factor receptor, c-kit. However, on differentiation of endothelial progenitors to mature endothelial cells, c-kit expression is lost in conjunction with de novo appearance of the mature endothelial cell markers vWF and VEcadherin. 21, 22 Studies conducted over the past five years have shown that neovascularisation in the adult is not only the result of in situ proliferation of mature endothelial cells but that bone marrow-derived progenitors also contribute. 23 The precise lineage and exact pathway of these progenitor cells' differ-ORIGINAL ARTICLE * entiation remain the focus of intense interest, although their origin from bone marrow is well established. 8 In the present study, we used c-kit as a marker of bone marrow lineage. 8 A large proportion of c-kit + cells were also found to express vWF, a large multimeric protein synthesised by endothelial cells (and also megakaryocytes). Indeed, the co-expression of c-kit and vWF along with the appearance of lumen formation together indicate their contribution to new vessel formation in the diabetic mesentery. Although it is possible that the findings of the present study may represent transdifferentiation of mature endothelial cells into c-kit + amorphous cells, there is no precedent for either the cytological changes or the de novo expression of c-kit by this cell type. Furthermore, the role of c-kit + cells may be important in the diabetic context in other cell types. 24 Chemokines were first recognised for their role in directing progenitor cells to undergo further maturation at specific sites within the bone marrow or in the thymus. However, more recently their contribution to blood vessel formation in both the embryo and in the mature organism has become apparent. For instance, mice that are deficient in the CXC chemokine, SDF-1 alpha show impaired vascularisation 25 while its subcutaneous injection 26 or gene transfer into adult mice leads to new vessel formation. 27 These effects of SDF-1 alpha are confined to cells that express its only receptor, CXCR4. In the present study, we show that not only is there a substantial upregulation in SDF-1 alpha expression in the diabetic mesentery but that this is also associated with dramatic infiltration of cells expressing both c-kit + and CXCR4.
The present study used the well described mesenteric model of experimentally induced diabetic angiogenesis 5, 6 to explore the mechanisms of new vessel formation. While this model provides a useful method of exploring the pathogenetic mechanisms that contribute to neoangiogenesis in diabetes, these studies cannot necessarily be extrapolated to other sites of diabetic pathology, particularly the retina, where the absence of a rodent model of proliferative diabetic retinopathy has been a major limiting factor.
